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Abstract 
Background: In the United States, 5.7 million patients are admitted annually to intensive care 
units (ICU), with costs exceeding $82 billion. Although close monitoring and dynamic 
assessment of patient acuity are key aspects of ICU care, both are limited by the time 
constraints imposed on healthcare providers.     
Methods: Using the University of Florida Health (UFH) Integrated Data Repository as Honest 
Broker, we created a database with electronic health records data from a retrospective study 
cohort of 38,749 adult patients admitted to ICU at UF Health between 06/01/2014 and 
08/22/2019. This repository includes demographic information, comorbidities, vital signs, 
laboratory values, medications with date and timestamps, and diagnoses and procedure codes 
for all index admission encounters as well as encounters within 12 months prior to index 
admission and 12 months follow-up. We developed algorithms to identify acuity status of the 
patient every four hours during each ICU stay. 
Results: We had 383,193 encounters (121,800 unique patients) admitted to the hospital, and 
51,073 encounters (38,749 unique patients) with at least one ICU stay that lasted more than 
four hours. These patients requiring ICU admission had longer median hospital stay (7 days vs. 
1 day) and higher in-hospital mortality (9.6% vs. 0.4%) compared with those not admitted to the 
ICU. Among patients who were admitted to the ICU and expired during hospital admission, 
more deaths occurred in the ICU than on general hospital wards (7.4% vs. 0.8%, respectively). 
Conclusions: We developed phenotyping algorithms that determined patient acuity status 
every four hours while admitted to the ICU. This approach may be useful in developing 
prognostic and clinical decision-support tools to aid patients, caregivers, and providers in shared 
decision-making processes regarding resource use and escalation of care. 
  
INTRODUCTION 
In the United States, 5.7 million patients are admitted annually to intensive care units (ICUs), with 
costs exceeding $82 billion. The annual cost of care delivered to these patients exceeds 4.1% of 
our national health expenditures,1 while ICU mortality ranges from 10% to 29%.2  
Close monitoring and dynamic assessment of patient acuity are key aspects of ICU care; both 
are limited by the time constraints imposed on healthcare providers. Assessment of patient acuity 
in the ICU relies almost exclusively on physicians’ clinical judgment and vigilance. There is a 
critical unmet need for assessment of the patient with continuous physiologic measurement and 
clinical data. 
ICU physicians spend only 9.4% of their clinical time in direct patient contact.3 Similarly, most ICU 
nurses spend only 10% of their time on direct patient assessments of pain and mobility.4 Patients 
may not be directly observed by physicians or nurses for 80% of their stay in an ICU. Both self-
report and manual observations suffer from subjectivity, poor recall, and limited number of 
administrations per day, and may lead to missed opportunities for timely interventions.5-9  
Manual and repetitive patient assessments result in personnel shortages and burnout. Critical 
care teams are under significant work pressure.10 Almost a third of ICU nursing teams suffer from 
burnout.11 High nursing workload is one factor in the occurrence of life-threatening adverse events 
in the ICU.12-16 Given this burden,17 there is an urgent need for automation of routine tasks.18 
Autonomous assessments can enhance critical care workflow efficiency by facilitating routine 
nursing assessments in the ICU and allow nurses to spend time on more critical tasks.  In addition, 
assessments that are associated with prognosis and clinical trajectory have the potential to 
augment prognostication and decisions regarding escalation of care and resource use.  
In this study, we developed computable phenotypes for acuity status that will be used to determine 
clinical trajectories in the ICU, which will be used in the future to develop a precise clinical 
trajectory prediction tool by utilizing high-resolution physiological signals and digital EHR data.  
 
METHODS 
Study design  
This study was approved by the University of Florida Institutional Review Board and Privacy 
Office (#IRB201600223 and #IRB201600262) as an exempt study with a waiver of informed 
consent. 
Data Source 
Using the University of Florida Health Integrated Data Repository as Honest Broker, we created 
a single center longitudinal dataset extracted directly from electronic health records of all 
patients who underwent surgery at the University of Florida Health in Gainesville, Florida 
between June 1, 2014 and May 1, 2019. This repository includes demographic information, 
comorbidities, vital signs, laboratory values, medications with date and timestamps, and 
diagnoses and procedure codes for all index admission encounters as well as encounters within 
12 months prior to the index admission and 12 months after admission.  All electronic health 
records were de-identified, except that dates of service were maintained. The dataset includes 
structured and unstructured clinical data, demographic information, vital signs, laboratory 
values, medications, diagnoses, and procedures.  
Participants 
We included 383,193  hospital encounters from 121,800 patients with age 18 years or older that 
were admitted to UF Health between June 1, 2014 and August 22, 2019. Among these hospital 
encounters, there were 51,073 encounters (38,749 unique patients) with at least one ICU stay 
that lasted more than four hours. 
Definition of Acuity Status 
At the end of each four-hour interval, for patients who have not died or discharged alive, acuity 
status was determined as unstable vs stable. Patient was considered as unstable if patient 
required at least one of the life supportive therapies: vasopressors, mechanical ventilation, 
continuous renal replacement therapy, or massive blood transfusion (defined as at least 10 units 
in past 24 hours). Otherwise, the patient was labeled as stable. (Figure 1) 
  
Figure 1. Flowchart for logic for phenotyping acuity status in ICU 
Data elements and rules used for identification of instability 
Data elements used for identification of acuity status are provided in Table S1. Computable 
phenotyping algorithms used rule-based approach as detailed below: 
Identification of ICU stay 
We identified date and time during which patient is an ICU room which were adjudicated by 
clinicians. ICU stays which are within 24 hours of each other were merged together. 
Identification of Vasopressor Use 
Use of vasopressors was identified by checking existence of at least one of the RxNorms listed 
in Table 1 for epinephrine, vasopressin, phenylephrine, norepinephrine, droxidopa, or ephedrine 
during the time interval of interest.  
Table 1. Identification of vasopressors using RxNorms 
Vasopressor 
Name 
RxNorm 
Epinephrine 1001079, 1001082, 1001086, 1001089, 1010677, 1010683, 1010688, 
1010745, 1010751, 1010759, 1012377, 1012384, 1012391, 1012707, 
107602, 107606, 1305268, 141848, 203180, 214547, 237187, 24255, 
245317, 284622, 310115, 310116, 310132, 310133, 310134, 313963, 
313967, 314610, 362, 3992, 66887, 691245, 727345, 727347, 727373, 
727374, 727386 
Vasopressin 11149, 374283, 313578 
Phenylephrine 8163, 8164, 373369, 373370, 374570, 373372, 379042 
Norepinephrine 242969, 7508, 7512, 1745276 
Droxidopa 1489913, 1490026, 1490034, 1490038 
Ephedrine 248717, 1115910, 214538, 310110, 1116191, 91165, 1116195, 1116294, 
198918, 1116146, 91166, 1115991, 310109, 387570, 3966, 5032, 991423 
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Identification of continuous renal replacement therapy 
We identified continuous renal replacement therapy (CRRT) using crrt file provided by IDR 
which includes identifiers, date and time stamp, and treatment type. We identify timeframes 
during which treatment type is continuous veno-venous hemofiltration (CVVH), continuous 
veno-venous hemodialysis (CVVHD), or, Continuous veno-venous hemodiafiltration (CVVHDF).  
Identification of Massive Blood Transfusion 
For each 4 hour interval, we determined whether the total amount of blood transfusion in the last 
24 hours exceeded 10 units. We identified whether there was a massive blood transfusion using 
transfusion file, provided by IDR, which includes procedure description, amount of transfusion, 
date and time stamp for order, start, and end of transfusion. We only considered red blood cell 
transfusion based on procedure description. If there was at least one of the start or end date 
and time, amount was imputed as 1 unit. If amount was not missing, but either start or end date 
and time was missing, the missing one was calculated assuming the duration between start and 
end is equal to the median duration between start and end date time in the cohort which is 1.5 
hours. If both start and end date time were missing, start date and time was imputed assuming 
duration between order date and time and start date and time is the median duration in the 
cohort which is 1.58 hours, and end date time was imputed by adding 1.5 hours to imputed start 
date and time. (Figure 2) 
Identification of Mechanical Ventilation Use 
We identified use of mechanical ventilation using respiratory file, provided by IDR, which has 
identifiers, date and time, respiratory device, ventilation mode, measured values for respiratory 
vitals that includes; oxygen flow rate, tidal volume, end-tidal carbondioxide (etCO2), and peep. 
Patient is assumed to be on mechanical ventilation if at least one of the tidal volume, end-tidal 
carbondioxide (etCO2), peep, mechanic respiratory rate or ventilation mode is not missing or 
respiratory device is ventilator or endotracheal tube (ETT). Device is assumed to be same until 
there is a change in device type.  (Figure 3)
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Figure 2. Flowchart for massive blood transfusion indication
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Figure 3. Identification of Mechanical Ventilation Use 
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Acuity Status patterns derivation 
To understand how the acuity status evolve in ICU, once we determined the acuity status every 
four hours, we used the k-means clustering method to derive the potential patterns. Acuity 
status in first 3 days were included. For those admissions with less than three days, we pad the 
missing acuity status as stable if the final status is discharge from ICU; if not, the missing acuity 
status are labeled as unstable. Thus for each ICU admission, we had 18 (3 * 24 / 4 = 18) acuity 
status as clustering features feeding to clustering method. 
Patterns of acuity states were visualized by line plots which illustrate the average value of acuity 
status across phenotypes over time along with 95% confidence interval for each estimate.  
 
RESULTS 
Patients 
We had 383,193 encounters (121,800 unique patients) admitted to the hospital, and 
51,073 encounters (38,749 unique patients) with at least one ICU stay that lasted more than 
four hours (Table 2). These patients requiring ICU admission had longer median hospital stay (7 
days vs. 1 day) and higher in-hospital mortality (9.6% vs. 0.4%) compared with those not 
admitted to the ICU. Among patients who were admitted to the ICU and expired during hospital 
admission, more deaths occurred in the ICU than on general hospital wards (7.4% vs. 0.8%, 
respectively).  
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Table 2. Clinical characteristics of cohort 
  
UF Health Hospital 
Admissions  
(06/01/2014-
08/22/2019) 
Number of patients 121,800 
Number of encounters 383,193 
   
Number of patients with at least one ICU stay 38,749 
Number of encounters with at least one ICU stay 51,073 
Number of ICU stays 54,178 
Hospital admissions, n 383,193 
Hospital LOS, days, median (25th, 75th)  2 (1, 4) 
In-hospital mortality, n (%) 6240 (1.6)  
   Never to ICU admissions, n (%) 332,120 (86.7) 
      Hospital LOS, days, median (25th, 75th) 1 (1, 3) 
      In-hospitality mortality, n (%) 1346 (0.4) 
   ICU admissions, n (%) 51,073 (13.3) 
      Hospital LOS, days, median (25th, 75th) 7 (4, 13) 
      ICU LOS, days, median (25th, 75th) 4 (2, 7) 
      In-hospitality mortality, n (%) 4894 (9.6) 
      Death within 7-days of ICU admission, n (%)    2984 (5.8) 
      Number of intervals from ICU admission to hospital discharge 35 (18, 65) 
      ICU admissions died in ICU, n (%) 3775 (7.4) 
          Hospital LOS, days, median (25th, 75th)    6 (3, 14)  
          ICU LOS, days, median (25th, 75th) 4 (2, 10) 
          Death within 7-days of ICU admission, n (%)    2534 (5.0) 
          Number of intervals from ICU admission to hospital discharge 25 (9, 61) 
      ICU admissions died in Ward, n (%) 389 (0.8) 
          Hospital LOS, days, median (25th, 75th) 12 (7, 20)  
          ICU LOS, days, median (25th, 75th) 5 (3, 9) 
          Death within 7-days of ICU admission, n (%) 161 (0.3) 
          Number of intervals from ICU admission to hospital discharge 55 (31, 91) 
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Distribution of acuity status 
Distributions of acuity status within first 15 days of ICU admission are illustrated in Figure 4. 
Four acuity status as stable, unstable, discharge from ICU, and dead in ICU were included. 
Number of encounters in ICU decreased rapidly from more than 50,000 to 10,000 encounters 
within first seven days, consistent with the 75th percentile ICU days. Every four hours primarily 
consisted of stable and unstable acuity status, and very few discharges and deaths. The 
percentage of stable acuity status first increased for 24-48 hours following ICU admission and 
then gradually decreased over time for approximately two weeks. The maximum percentages of 
patients who were discharged or died during each four-hour period were 1.83% and 0.38% 
respectively.  
 
Figure 4. Distribution of acuity status within first 15 days in ICU 
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Transition probability matrix of acuity status 
The transition probability matrix of acuity status was listed in Table 3 and illustrated in Figure 5 
for all transitions from ICU admission to ICU discharge. Stable acuity status transited to stable 
status within next 4 hours with a high probability (93.0%), and to unstable status with probability 
(2.2%). Unstable acuity status transited to unstable status within next 4 hours with a high 
probability (93.0%), and to stable status with probability (6.6%). Patients with stable acuity 
status are more likely to discharge from ICU compared with unstable acuity status (4.6% vs. 
0.0%). Patients with unstable acuity status are more likely to dead in ICU compared with stable 
acuity status (0.4% vs. 0.1%). 
Table 3. Transition probability matrix of acuity status 
 Acuity status within next 4 hours 
 Stable Unstable Discharge Dead 
Stable 93.0% 2.2% 4.6% 0.1% 
Unstable 6.6% 93.0% 0.0% 0.4% 
 
Figure 5. Acuity state transitions in every 4 hr interval from ICU admission to ICU discharge 
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Phenotypes of acuity status 
Three phenotypes of acuity status were derived (Figure 6). Cluster 1 was mainly manifested as 
stable acuity status. This cluster had the most patients (35844, 70%), lowest mortality (2.5%), 
shortest median ICU stay (3 days) and hospital stay length (6 days). Cluster 2 presented with 
persistent unstable acuity status. As a result, this cluster contained the patients (9619, 19%) 
with highest mortality (31.8%) and longest median ICU stay (8 days) and hospital stay length 
(12 days). Cluster 3 first presented with unstable acuity state, and then gradually back to stable 
acuity state. This cluster contained patients (5610, 11%) with second lowest mortality (3.5%), 
and median ICU stay (4 days) and hospital stay length (8 days).  
 
Figure 6. Acuity status distribution across phenotypes within first three days of ICU admission 
 
 
 
 
 
 
 
16 
 
 
DISCUSSION 
These findings demonstrate that during the first 24 to 48 hours after ICU admission, there is an 
increase in the raw number and percentage of ICU patients who are stable.  After this point, 
rates of discharge from the ICU, including death in the ICU, remain constant, and the remaining 
population of ICU patients shifts toward the unstable phenotype.  This trend continues for 
approximately two weeks after ICU admission, consistent with clinical definitions of chronic 
critical illness. 19,20  For both stable and unstable acuity types, there was a 93% probability that 
the following acuity state would be unchanged.  The probability of death during the following 
four-hour period was approximately 4-hold higher among unstable vs. stable patients, 
suggesting that our methods for classifying patient acuity by vasopressors, massive blood 
product transfusions, mechanical ventilation, and renal replacement therapy were effective in 
identifying patients at increased risk for death.  Finally, we identified three patient clusters of 
patients, one that remained stable, one that was persistently unstable, and one that was 
unstable at the time of ICU admission but transitioned to stability within 48 hours.  Identifying 
these clusters has potential clinical utility for informing discussions among patients, caregivers, 
and providers regarding prognosis, and informing decisions regarding resource use.  This task 
can be automated, without requiring additional patient assessments by ICU health care workers, 
who face worsening work force shortages and job-related stress.      
At the time of ICU admission for an unstable patient, patients and their caregivers may 
wish to embark on a course of aggressive, life-sustaining treatments if there is a high probability 
of recovery and transition to stability.  Some critically ill patients have previously expressed a 
desire to forego prolonged life-sustaining treatments.  In these cases, providing the patient and 
their caregivers with information to suggest that the probability of early recovery is low could 
augment their decision-making process and alleviate the stress associated with the decision to 
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forgo aggressive, resource-intense therapy.  Therefore, identifying acuity phenotypes has the 
potential to augment clinical prognostication and decision-making.   
This study was limited by a single-institution design, which limits its generalizability to 
other practice settings.  We made binary distinctions between stable and unstable patients 
because these distinctions facilitate the identification of transitions in acuity states and clustering 
based on these states.  However, we recognize that true patient acuity actually exists on a 
continuum.  It remains unknown whether identifying acuity states and clusters will affect 
prognostication and decision-making in the clinical setting; this is a target for future research.   
 
CONCLUSION 
We developed phenotyping algorithms that determined patient acuity status every four 
hours while admitted to the ICU. This task can be automated, which has the advantage of 
avoiding additional patient assessments by ICU health care workers, who already face 
worsening work force shortages and job-related stress. Automated acuity phenotyping has the 
potential to leverage high-resolution physiological signals and digital EHR data to develop 
prognostic and clinical decision-support tools that aid patients, caregivers, and providers in 
shared decision-making processes regarding resource use and escalation of care.   
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Table S1. Data elements that are used to run acuity phenotyping algorithm 
 
Used for 
identification of 
Features Description  Format  
Identifier patient_deiden_id Deidentified Patient ID Strings 
Identifier encounter_deiden_id Deidentified Encounter 
ID  
Strings 
Continuous renal 
replacement 
therapy 
meas_value Measured Value Measured Value 
Continuous renal 
replacement 
therapy 
recorded_time Recorded Time The date and time value was recorded 
Continuous renal 
replacement 
therapy 
vital_sign_group_na
me 
Name of the measured 
variable 
Group name of vital sign. Values 
include: Device Number, Hourly Net 
Balance, Maintenance, Output (mL), 
Presctiption, Therapy, or Treatment. 
Continuous renal 
replacement 
therapy 
vital_sign_measure_
name 
Name of the measured 
variable 
Name of the measured variable 
Mechanical 
Ventilation respiratory_datetime Respiratory DateTime 
The date and time when the 
respiratory device is used 
Mechanical 
Ventilation respiratory_device Respiratory Device 
The device being used to deliver 
oxygen or move air in and out of the 
lungs  
Mechanical 
Ventilation adult_vent_mode Adult Ventilator Mode 
The breathing pattern programmed 
into the mechanical ventilator, which is 
moving air in and out of the lungs 
Mechanical 
Ventilation 
adult_mech_resp_rat
e 
Mechanical Respiratory 
Rate 
Breaths per minute for a patient on a 
mechanical ventialtor/breathing 
machine 
Mechanical 
Ventilation peep 
End of Expiratory 
Pressure 
The pressure in the airways at the end 
of exhalation (mm Hg or cm H20) 
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Mechanical 
Ventilation tidal_volume Tidal Volume (mL) 
The volume of air that moves with 
each breath (mL) 
Mechanical 
Ventilation etco2 
End-tidal Carbon Dioxide 
Amount 
The amount of CO2 in the air that is 
moving out of the lungs (mm Hg) for 
patients on mechanical ventilation and 
without invasive airway, fio2 
Massive blood 
transfusion blood_end_instant 
Blood transfusion end 
date and time Blood transfusion end date and time 
Massive blood 
transfusion blood_start_instant 
Blood transfusion start 
date and time Blood transfusion start date and time 
Massive blood 
transfusion frequency 
Amount of blood 
transfusion 
Amount of blood transfusion as 
Transfuse X units 
Massive blood 
transfusion procedure_desc 
Description of the 
procedure 
Description of the procedure as 
Transfuse Red Blood 
Cells/Plasma/Platelets/… 
Vasopressor Use taken_datetime Action Taken DateTime Time at which MAR action was logged 
Vasopressor Use 
med_order_display_n
ame 
Medication Order 
Display Name Medication order display name 
Vasopressor Use rxnorm_concat 
Concatenated 
Medication Name 
The concatenated medical name of the 
medicine 
Vasopressor Use mar_action 
Medical Administration 
Record Action Taken 
Medical administration record action 
taken 
Vasopressor Use 
med_order_discrete_
dose 
Medication Order 
Discrete Dose 
The dosage at which the medication 
needs to be administered 
Vasopressor Use med_order_route Medication Order Route 
The medium through which the 
medication is administered 
Vasopressor Use 
med_order_discrete_
dose_unit 
Medication Order 
Discrete Dose Unit The units of the medication dosage 
Vasopressor Use 
height_weight_dateti
me 
Height and Weight 
Measured DateTime 
The date and time that the patient's 
height and weight are measured. 
Vasopressor Use weight_kgs Weight (kgs) Patient's weight in kilograms (kg) 
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